Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-27

Clinical Trial Update: The Use Of Liposomal Bupivacaine For Pain Control [Phase 4]

View source ↗

Summary

Phase 4 trial update on the use of liposomal bupivacaine for pain control in breast pain indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Pain, Breast | Phase 4 | Status: COMPLETED | Results posted: 2022-10-27